french study
Recently Published Documents


TOTAL DOCUMENTS

276
(FIVE YEARS 67)

H-INDEX

27
(FIVE YEARS 3)

Author(s):  
Mickael Mangin ◽  
Florent Galliot ◽  
Fayçal Houfani ◽  
Cédric Baumann ◽  
Didier Mainard

2021 ◽  
Vol 12 ◽  
Author(s):  
Aude Triquenot Bagan ◽  
Isabelle Crassard ◽  
Ludovic Drouet ◽  
Marianne Barbieux-Guillot ◽  
Raphaël Marlu ◽  
...  

Introduction: Cerebral venous thrombosis (CVT) is a rare disease with highly variable clinical presentation and outcome. Etiological assessment may be negative. The clinical and radiological presentation and evolution can be highly variable. The mechanisms involved in this variability remain unknown.Objective: The aim of this multicenter French study registered on ClinicalTrials.gov (NCT02013635) was therefore to prospectively recruit a cohort of patients with cerebral venous thrombosis (FPCCVT) in order to study thrombin generation and clot degradation, and to evaluate their influence on clinical radiological characteristics. The first part of the study was to compare our cohort with a reference cohort.Methods: This prospective, multicenter, French study was conducted from July 2011 to September 2016. Consecutive patients (aged >15 years) referred to the stroke units of 21 French centers and who had a diagnosis of symptomatic CVT were included. All patients gave their written informed consent. The diagnosis of CVT had to be confirmed by imaging. Clinical, radiological, biological, and etiological characteristics were recorded at baseline, at acute phase, at 3 months and at last follow-up visit. Thrombophilia screening and the choice of treatment were performed by the attending physician. All data were compared with data from the International Study on CVT published by Ferro et al.Results: Two hundred thirty-one patients were included: 117 (50.6%) had isolated intracranial hypertension, 96 (41.5%) had focal syndrome. During hospitalization, 229 (99.1%) patients received anticoagulant treatment. Median length of hospital stay was 10 days. Five patients died during hospitalization (2.2%). At 3 months, 216 patients (97.0%) had follow-up with neurological data based on an outpatient visit. The mean duration of antithrombotic treatment was 9 months, and the mean time to last follow-up was 10.5 months. At the end of follow-up, eight patients had died, and 26 patients were lost to follow-up. At least one risk factor was identified in 200 patients.Conclusions: We demonstrated that the FPCCVT cohort had radiological, biological, and etiological characteristics similar to the historical ISCVT cohort. Nevertheless, the initial clinical presentation was less severe in our study probably due to an improvement in diagnostic methods between the two studies.


Author(s):  
Aymeric Becq ◽  
Iradj Sobhani ◽  
Blandine Vauquelin ◽  
Thomas Guilmoteau ◽  
Martin Bordet ◽  
...  

2021 ◽  
Vol 45 (6) ◽  
pp. 101607
Author(s):  
Clémence Breton ◽  
Antoine Meyer ◽  
David Malka ◽  
Margarida Matias ◽  
Thierry De Baere ◽  
...  

Author(s):  
Jason Philippe Shourick ◽  
Claire Simone-Marie Laurent ◽  
Georges Mion ◽  
Charbel Louis Skayem ◽  
Pierre Michel-Gilbert Hamann

Background: Coronavirus disease 2019 (COVID-19) has changed the practice of all health-care professionals. Determining the impact could prevent repercussions in future crisis. Objectives: The objectives of the study were to assess the impact of the COVID-19 pandemic on dermatology residents’ professional practice, working conditions, academic training and mental health. Methods: An online questionnaire was sent to all French dermatology residents. We compared the activity of residents working in areas heavily impacted by COVID-19 to others. Logistic multivariate regressions were done, using as outcome variables the negative impact of the COVID crisis on residents’ possibility to practice dermatology during the crisis, supervision, academic training and working more than 50 h/week. The last part of the questionnaire was the burnout questionnaire of Maslach. Results: A total of 246 residents filled the questionnaire. Residents working in highly impacted COVID areas (odds ratio, OR 0.34 confidence interval, CI [0.18, 0.61], P ≤ 0.001), first-year postgraduate (PGY-1) residents (OR 0.46 CI [0.23, 0.91], P = 0.023) and those in private practice (OR 0.10 CI [0.01, 0.57], P = 0.032) were significantly less able to maintain dermatology activities. Worse supervision was significantly more frequent with non-PGY-1 residents (OR 3.24 CI [1.65, 6.65], P < 0.001). One hundred and eighty one residents claimed the pandemic to have a negative effect on their dermatology curriculum with no difference according to their regions’ affection by COVID-19. This was mostly attributed to the cancelation of courses and congresses. PGY-1 residents (OR 2.09 CI [1.09, 4.04], P = 0.029) and residents in highly affected areas (OR 1.79 CI [1.01, 3.18], P = 0.049) were more at risk of working above the maximal legal working time. None of the residents was free of burnout symptoms. Conclusion: Dermatology residents have been highly affected by COVID-19. It might be important to have a more integrated healthcare system to fight times of crisis with the least repercussions on residents.


2021 ◽  
Vol 156 ◽  
pp. S35-S36
Author(s):  
Gilles Battesti ◽  
Caroline Ram-Wolff ◽  
Gabor Dobos ◽  
François Aubin ◽  
Marie-Paule Algros ◽  
...  

2021 ◽  
Vol 16 (10) ◽  
pp. S1205
Author(s):  
C. Clément-Duchêne ◽  
P. Gilson ◽  
S. Lacomme ◽  
C. Yguel ◽  
S. Renaud ◽  
...  

2021 ◽  
pp. 112067212110443
Author(s):  
Chloé Chamard ◽  
Héléna Huguet ◽  
Alain M Bron ◽  
Catherine Creuzot-Garcher ◽  
Erika Nogue ◽  
...  

Purpose: Cataract and glaucoma are among the leading causes of blindness worldwide in older people, and they are often concomitant. To assess topical intraocular (IOP)-lowering agents delivery changes after cataract extraction. Material and methods: Longitudinal matched exposed–unexposed study from the French national healthcare database from January 1, 2005 to January 1, 2017. We compared individuals using topical IOP-lowering agents who underwent bilateral cataract extraction with individuals matched on IOP-lowering agents load, age, and sex who did not undergo cataract extraction. IOP-lowering agents number of drops was assessed 12 months before the first cataract extraction and compared with number of drops 12 months after the second cataract extraction. Results: About 1194 individuals treated with IOP-lowering agents were included, 597 exposed to bilateral cataract extraction and 597 unexposed to any surgery (total mean age 74.8 ± 8.3 years; 69.0% women). Mean IOP-lowering agents delivery at baseline was 1.4 daily drops in both groups. The mean number of drops decreased greater in the exposed than unexposed group (−25.5% vs −3.5%; p < 0.0001). Overall, 159 (26.6%) and 48 (8.0%) individuals in the exposed and unexposed groups interrupted medication ( p < 0.0001). Conclusions: A decrease of around one quarter of IOP-lowering agents delivery was observed after cataract extraction in the present real-life study with a longstanding interruption observed in one quarter of patients. Phacoemulsification as a standalone procedure reduces IOP-lowering agents delivery in ocular hypertension and glaucoma.


Dermatology ◽  
2021 ◽  
pp. 1-6
Author(s):  
Flavien Huet ◽  
Charles Taieb ◽  
Florence Corgibet ◽  
Emilie Brenaut ◽  
Marie-Aleth Richard ◽  
...  

<b><i>Background:</i></b> The prevalence and impact of pruritus, pain, and other sensory symptoms in skin diseases are poorly known. <b><i>Objective:</i></b> To assess the frequency of these symptoms with dermatoses and their association with depression using data from the “Objectifs Peau” survey. <b><i>Methods:</i></b> A representative sample of 20,012 French individuals was created using the usual quota method. <b><i>Results:</i></b> When patients suffered from both pruritus and skin pain, they had a higher relative risk of psychological suffering (2.9) than those who suffered only from pruritus (1.4) or skin pain (1.2). Pruritus was reported in 48.55% of patients with acne, 43.24% with mycoses, 44.35% with warts, and 36.51% with rosacea. For skin pain, the results were 11.22%, 27.59%, and 16.13% for atopic dermatitis, acne, and warts, respectively. Other unpleasant sensations, such as tingling or burning, were also frequently reported. <b><i>Conclusion:</i></b> Pruritus, pain, or other sensory symptoms were found to be common not only in classic pruritic skin diseases but also in acne, rosacea, or warts. The association of pruritus and pain dramatically increased psychological suffering. These symptoms must be systematically searched for in patients, especially since new therapeutic possibilities are emerging for the symptomatic treatment of pruritus.


Sign in / Sign up

Export Citation Format

Share Document